First BTM patient in US

February 22 2017

PolyNovo Limited (“PolyNovo”) is pleased to announce the first US patient has been treated with our Biodegradable Temporising Matrix (BTM).

Read more

South Africa – 1st Order

February 21 2017

PolyNovo Limited (“PolyNovo”) is pleased to announce our first Biodegradable Temporising Matrix (BTM) order in South Africa.

Read more

PolyNovo signs South African Distribution Agreement

December 8 2016

Tony Lowther MD of Ascendis Medical attended the PolyNovo office for the signing of the agreement. It is great to have Tony and his Team working with PolyNovo.

Read more

PolyNovo Owens & Minor Agreement 3PL USA

December 2 2016

PolyNovo is pleased to announce the appointment of Owens and Minor (O&M) as its strategic logistics partner (3PL) in the United States (US).

Read more

PolyNovo – Silver Sponsor of 2017 ANZBA conference

November 14 2016

Read more

Australia & New Zealand Distribution Agreement

October 10 2016

PolyNovo & Device Technologies distribution agreement.

Read more

US Direct Market Entry

October 3 2016

PolyNovo announces the direct market entry into the US market with our own sales team.

Read more

New Branding for PolyNovo

August 16 2016

New Branding/Logo reflecting our move towards a commercial enterprise.

Read more

Newspaper PolyNovo & Beta Cell

July 29 2016

This Adelaide newspaper article outlines how the technologies may address some aspects of diabetes treatments in the future.

Read more

TV segment: BTM in Diabetes Reseach

July 27 2016

Adelaide Ch:10 TV article on the BTM use in Diabetes research.

Read more

BTM use in Diabetes Islet Cell Transplantation Study

July 25 2016

Read more

A Novel Biodegradable Polyurethane Matrix for Auricular Cartilage Repair: An In Vitro and In Vivo Study

July 11 2016

Read more

PolyNovo Silver Sponsorship at ANZBA 2016

June 14 2016

PolyNovo is pleased to be a silver sponsor of the 2017 ANZBA (Burns) Conference being held in Adelaide in October 2017.

Read more

Additional BARDA Option Exercised Valued at US$2.4m

May 31 2016

ASX Announcement of the start of the BARDA funded feasibility trials in US.

Read more

Bioshares write up of PNV Feb 2016

May 3 2016

A newsletter write up of PolyNovo and the changes in focus over the past 18 months.

Read more

Feasibility Trial Investigators Meeting

May 3 2016

ASX Announcement of the start of the BARDA funded feasibility trials in US.

Read more

CEO Sessions

April 30 2016

This is the synchronized slide presentation from the ASX/FNN CEO Sessions in Melbourne 19 April.

Read more

ASX CEO presentations April 2016

April 19 2016

An update on PolyNovo commercialisation.

Read more

ASX CEO presentations April 2016

April 19 2016

An update on PolyNovo commercialisation.

Read more

Investor Presentation Feb10

March 17 2016

Read more

Bailieu Holst Analyst summary Report

February 1 2016

PNV is a Melbourne based medical device company that designs and manufactures solutions for its NovoSorb biodegradable polymer technology.

Read more

Expanded US FDA Announcement

February 1 2016

PNV is a Melbourne based medical device company that designs and manufactures solutions for its NovoSorb biodegradable polymer technology.

Read more

PolyNovo in The Australian (Newspaper)

February 1 2016

Read more

BTM achieves US FDA 510(k) approval

February 1 2016

Read more